Dr. Ampajwala is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9990 Dallas Pkwy
Suite 200
Frisco, TX 75033Phone+1 214-387-8288Fax+1 214-387-8289
Summary
- Madhavi Ampajwala, MD, is a Family Medicine specialist based in Frisco, TX. She completed her residency in Family Medicine at Concord Hospital/New Hampshire-Dartmouth Family Medicine in 2007 and is a graduate of Kakatiya Medical College NTR. Dr. Ampajwala has been practicing as a physician at Village Health Partners and as an MD at the Catalyst physician group since 2008. Her primary areas of experience include hormone therapy, women's health, and wellness. She has made significant contributions to her field, with publications in The New England Journal of Medicine and Infectious Diseases and Therapy. Dr. Ampajwala also has participated in clinical trials focused on the acute treatment of migraines. Her dedication to quality care has earned her honors from the National Committee for Quality Assurance.
Education & Training
Concord Hospital/New Hampshire-Dartmouth Family MedicineResidency, Family Medicine, 2004 - 2007
Kakatiya Medical College NTRClass of 2001
Certifications & Licensure
TX State Medical License 2008 - 2025
NH State Medical License 2007 - 2009- American Board of Family Medicine Family Medicine
Awards, Honors, & Recognition
- Physician Practice Connections Recognition Program National Committee for Quality Assurance, 2010-2013
- Patient-Centered Medical Home Recognition Program National Committee for Quality Assurance, 2010-2013
Clinical Trials
- A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Assess STS101 in the Acute Treatment of Migraine Start of enrollment: 2021 Jun 30
Publications & Presentations
PubMed
- 57 citationsEvaluation of mRNA-1273 Vaccine in Children 6 Months to 5 Years of Age.Evan J Anderson, C Buddy Creech, Vladimir Berthaud, Arin Piramzadian, Kimball A Johnson
The New England Journal of Medicine. 2022-11-03 - 42 citationsA Rapid, High-Sensitivity SARS-CoV-2 Nucleocapsid Immunoassay to Aid Diagnosis of Acute COVID-19 at the Point of Care: A Clinical Performance Study.Paul K. Drain, Madhavi Ampajwala, Christopher Chappel, Andre B. Gvozden, Melanie Hoppers
Infectious Diseases and Therapy. 2021-02-24
Professional Memberships
- Member
Other Languages
- Telugu, Hindi
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
